Cancer Research Horizons: Investment Portfolio & Startup News
Cancer Research Horizons
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
52North raises £3.2m in funding led by Macmillan Cancer Support to support urgent cancer care diagnostics
52North is a medical technology spin-out from the University of Cambridge developing the Aster biomarker platform and Neutrocheck, a rapid finger-prick blood test. Neutrocheck supports remote triaging of chemotherapy patients at risk of neutropenic sepsis to reduce unnecessary emergency hospital visits.
Infinitopes secures an £11m seed round led by Octopus Ventures and Amplify Bio to prevent recurrence of oesophageal cancer
Infinitopes develops off-the-shelf precision cancer vaccines designed to prevent recurrence, using AI-powered immunomics to target shared tumour features and advance new immunotherapies into clinical trials.
Oncology medical tech startup 52North secures £5m with landmark UK-US hospital VC deal
52North builds medical devices and digital tools that support cancer patients outside hospital, focusing on early detection and monitoring of treatment-related complications to improve urgent oncology care pathways.
More venture news
- 26 Oct 2026
NousNous raises £13m in funding led by Heartcore Capital and Mosaic Ventures for an AI agent that manages household bills and admin
EquityConsumer - 19 Oct 2026
FrugaFruga secures a £1m in funding led by PXN Ventures to lower insurance renewal premiums through open banking
EquityFintech - 13 Oct 2026
SainapticSainaptic raises £1m in funding led by Cornerstone VC and Ufi Ventures for AI-assisted marking of vocational and professional qualifications
EquityEducation
